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Abstract
Objectives—Many parents recall hearing of HPV vaccine through drug company
advertisements. We sought to examine whether parents accurately recall the source (i.e., sponsor)
of ads promoting HPV vaccine and the impact of drug company ads.
Methods—A U.S. national sample of 544 parents of adolescent males ages 11–17 participated in
an online between-subjects experiment. Parents viewed an advertisement encouraging HPV
vaccination for boys with a logo from a randomly assigned source. Parents rated trust, likability,
and motivation for vaccination while viewing the ad and later indicated who they believed
sponsored it.
Results—Nearly half (43%) of parents who viewed a hypothetical advertisement containing a
logo incorrectly identified the ad source. More parents correctly identified the source of drug
company ads than ads from other sources (62% vs. 25%, OR 4.93, 95% CI 3.26–7.46). The
majority of parents who saw a logo-free ad believed a drug company created it (60%). Among
parents who correctly identified the ad source, drug company ads decreased motivation to
vaccinate their sons, an association mediated by reduced liking of and trust in the ads.
Conclusions—Parents were more accurate in identifying drug company ads, primarily because
they tended to assume any ad was from a drug company. Public health organizations may need to
take special measures to ensure their messages are not perceived as sponsored by drug companies.
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Introduction
Human papillomavirus (HPV) vaccine can prevent several cancers and genital warts.[1,2]
Guidelines recommend routine vaccination of boys,[3] though uptake is very low.[4] Many
parents recall hearing of HPV vaccine through drug company advertisements,[5] which may
be problematic as people find corporate sources less credible than non-profit or government
sources,[6] and credibility can affect intentions and behavior.[6,7] Thus, it is possible that
parents’ have negative reactions to drug company ads that hinder vaccine uptake. We
hypothesized that: (1) parent accuracy in identifying source would be only moderate because
extensive advertising of HPV vaccine by drug companies would make them the presumed
source; and (2) advertisements from drug companies would be less liked and trusted and
therefore less likely to motivate parents to vaccinate their sons.
Methods
Participants
Parents, who were in a survey panel and had at least one son ages 11–17, received an email
invitation to participate in our online survey in fall 2010.[8] The survey company developed
the panel from a probability-based sample of U. S. households. Of 1195 parents invited to
participate, 752 responded to the invitation, and of those, 72% (n=544) were eligible and
completed the survey. Demographic characteristics of respondents appear elsewhere.[4] The
Institutional Review Board at the University of North Carolina approved the study.
Procedures
We randomly assigned parents to one of ten conditions in a 5 (source of ad) × 2 (warning
text) between-subjects factorial experiment. They viewed a display ad (Appendix 1),
encouraging them to vaccinate their sons, with a randomly assigned logo that indicated
source: 1) Merck, 2) Gardasil, 3) Centers for Disease Control and Prevention (CDC), 4)
American Cancer Society (ACS), or 5) no logo. We chose the CDC and ACS because they
are credible alternative sources for information on HPV vaccine with widely disseminated
logos. There was no effect of an additional manipulation (the inclusion of safety information
warning text), so we do not discuss it further.
Measures
While viewing the ad, parents rated their agreement with these statements on a 4-point scale
(strongly disagree [coded as 1] to strongly agree [4]): “I like this ad”; “I trust this ad”; and
“This ad makes me want to vaccinate my son against HPV”. Once the ad was no longer on
screen, parents indicated whether the ad’s sponsor was a drug company, government agency,
charity for cancer, or insurance company. We coded parents’ responses as correct if they
selected “drug company” for ads with Merck or Gardasil logos; “government agency” for
ads with a CDC logo; or “charity for cancer” for ads with an ACS logo. Other response
combinations were incorrect.
Data Analysis
Using logistic regression, we examined whether actual ad source predicted ad source
misattribution. These analyses did not include participants who viewed an ad without a logo
because they could not, by definition, be correct about source.
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We used linear regression to examine the effects of perceived ad source (drug company
versus not a drug company, coded as 1 and 0) on parents’ ratings of likability, trust, and
motivation to vaccinate. This analysis excluded respondents who saw ads without logos or
inaccurately identified ad source, to eliminate those for whom the logo manipulation failed.
We examined trust and likability as potential mediators.[9] Analyses with SPSS version 17.0




Nearly half (43%) of parents who viewed a hypothetical advertisement containing a logo
incorrectly identified the ad source. More parents correctly identified the source of drug
company ads than ads from other sources (62% vs. 25%, OR 4.93, 95% CI 3.26–7.46). The
majority of parents who saw the logo-free ad believed it was created by a drug company
(60%).
Effect of Source
Among parents who correctly identified ad source (n=243), most agreed or strongly agreed
that they liked the ad (69%) and trusted it (60%). Fewer (38%) agreed or strongly agreed
that the ad made them want to get their sons HPV vaccine. Parents who correctly identified
drug company advertisements reported lower levels of liking, trust, and motivation to
vaccinate than those who correctly identified ads from another source (all p<.05).
Greater liking of (β=0.46, p<.001) and greater trust in the ad (β=0.31, p<.001) both
predicted greater motivation to vaccinate (Figure 1), but the association between source and
motivation became non-significant when controlling for liking and trust (β=−0.16, p=.01
without controlling; β=−0.02, p=.74 after controlling). This pattern suggests mediation: drug
company ads elicited lower liking and trust and, in turn, lower liking and trust reduced
motivation to vaccinate sons against HPV.
Discussion
Drug company ads motivated parents less to vaccinate, relative to non-drug company ads,
because parents liked and trusted the ads less. However, parents were more accurate in
identifying ads from drug companies than other sources, primarily because they tended to
assume any ad was from a drug company. Producing ads that are clearly not from drug
companies could help public health organizations increase HPV vaccine uptake. Approaches
could include providing a statement about the mission of the ad’s sponsor or prominently
displaying its contact information in the ad. Future studies should address the changing
context of HPV vaccination. Parents’ interest in HPV vaccine for their sons may rise now
that guidelines recommend administering the vaccine routinely to boys.[3] The relationship
between perceived source and attitudes toward vaccinating boys against HPV could change
as parents see more HPV vaccine-related messages.
Study strengths include an experimental design and a national sample. One limitation is the
self-reported vaccination intention outcome; however, intention is a key predictor of vaccine
uptake.[10] In addition, parents viewed the hypothetical vaccination ads as part of an
experiment, not in a real-world context. Finally, although this study used a national sample,
parents were from an online panel and mostly white and well-educated; generalizability
should be established.
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Ultimately, understanding links between ad sponsorship and parents’ attitudes may help
public health practitioners craft more effective promotion messages that parents could easily
distinguish from ones by drug companies.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Test of mediation. Among respondents who accurately identified ad source (n=243).
Numbers are standardized regression coefficients. Number in parenthesis shows the
association between source and motivation prior to controlling for liking and trusting the ad.
*p<.05 **p<.001
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